In spite of the significant advancements in the treatment modalities. 30% of advanced stage ovarian cancer (OC) patients do not respond to the standard chemotherapeutic regimen and most of the responders finally relapse over time due to the escalation of multidrug resistance (MDR) Phenomenon. Our present study evaluated chemotherapeutic sensitivity response among 47 ovarian tumor pati... https://www.chiggate.com/igora-vibrance-9-5-4-beige-toner-sale/